Literature DB >> 19360358

Tumor initiating cancer stem cells from human breast cancer cell lines.

Ji Seung Han1, David L Crowe.   

Abstract

Breast cancer is composed of heterogeneous cell populations with different biological properties. The capacity to form tumors resides in a small group of cells termed tumor initiating cells or cancer stem cells. Tumor initiating cells have been identified in a variety of cancers by sorting of subpopulations based on cell surface markers and transplantation into animal models. Tumor initiating cells have the important feature of self renewal, which is a property in common with stem cells. We examined established breast cancer lines for cells with tumor initiating properties. A dye efflux side population in MCF7 and T47D lines expressed markers of breast cancer stem cells. The side population represents a distinct morphologic and functional subpopulation within the human breast cancer cell lines MCF7 and T47D. The side population from human breast cancer cell lines was able to initiate tumors in vivo. The side population cells from human breast cancer cell lines were more resistant to ionizing radiation than the non-side population. We concluded that tumor initiating cells exist in established human breast cancer cell lines.

Entities:  

Mesh:

Year:  2009        PMID: 19360358

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  14 in total

1.  TGFbeta/TNF(alpha)-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype.

Authors:  Michael K Asiedu; James N Ingle; Marshall D Behrens; Derek C Radisky; Keith L Knutson
Journal:  Cancer Res       Date:  2011-05-09       Impact factor: 12.701

2.  Survival and self-renewing capacity of breast cancer initiating cells during fractionated radiation treatment.

Authors:  Chann Lagadec; Erina Vlashi; Lorenza Della Donna; Yonghong Meng; Carmen Dekmezian; Kwanghee Kim; Frank Pajonk
Journal:  Breast Cancer Res       Date:  2010-02-16       Impact factor: 6.466

3.  Comparative testing of various pancreatic cancer stem cells results in a novel class of pancreatic-cancer-initiating cells.

Authors:  Kshama R Jaiswal; Hong-Wu Xin; Andrew Anderson; Gordon Wiegand; Bo Kim; Tyler Miller; Danielle Hari; Satyajit Ray; Tomotake Koizumi; Udo Rudloff; Snorri S Thorgeirsson; Itzhak Avital
Journal:  Stem Cell Res       Date:  2012-08-19       Impact factor: 2.020

4.  Identification, expansion and characterization of cancer cells with stem cell properties from head and neck squamous cell carcinomas.

Authors:  Hatem O Kaseb; Helene Fohrer-Ting; Dale W Lewis; Eric Lagasse; Susanne M Gollin
Journal:  Exp Cell Res       Date:  2016-09-09       Impact factor: 3.905

5.  Targeting breast cancer-initiating/stem cells with melanoma differentiation-associated gene-7/interleukin-24.

Authors:  Sujit K Bhutia; Swadesh K Das; Belal Azab; Mitchell E Menezes; Paul Dent; Xiang-Yang Wang; Devanand Sarkar; Paul B Fisher
Journal:  Int J Cancer       Date:  2013-07-06       Impact factor: 7.396

6.  AML1-ETO mediates hematopoietic self-renewal and leukemogenesis through a COX/β-catenin signaling pathway.

Authors:  Yiyun Zhang; Jianfeng Wang; Justin Wheat; Xi Chen; Shan Jin; Hossein Sadrzadeh; Amir T Fathi; Randall T Peterson; Andrew L Kung; David A Sweetser; Jing-Ruey Joanna Yeh
Journal:  Blood       Date:  2013-05-03       Impact factor: 22.113

7.  Senescence evasion by MCF-7 human breast tumor-initiating cells.

Authors:  Feridoun Karimi-Busheri; Aghdass Rasouli-Nia; John R Mackey; Michael Weinfeld
Journal:  Breast Cancer Res       Date:  2010-06-02       Impact factor: 6.466

8.  Conversion of stationary to invasive tumor initiating cells (TICs): role of hypoxia in membrane type 1-matrix metalloproteinase (MT1-MMP) trafficking.

Authors:  Jian Li; Stanley Zucker; Ashleigh Pulkoski-Gross; Cem Kuscu; Mihriban Karaayvaz; Jingfang Ju; Herui Yao; Erwei Song; Jian Cao
Journal:  PLoS One       Date:  2012-06-05       Impact factor: 3.240

9.  Establishment and characterization of two human breast carcinoma cell lines by spontaneous immortalization: Discordance between Estrogen, Progesterone and HER2/neu receptors of breast carcinoma tissues with derived cell lines.

Authors:  Behnam Kamalidehghan; Massoud Houshmand; Fereydoun Kamalidehghan; Narges Jafarzadeh; Shahram Azari; Sharifah Noor Akmal; Rozita Rosli
Journal:  Cancer Cell Int       Date:  2012-10-29       Impact factor: 5.722

10.  Established breast cancer stem cell markers do not correlate with in vivo tumorigenicity of tumor-initiating cells.

Authors:  Christian Lehmann; Gabriele Jobs; Markus Thomas; Helmut Burtscher; Manfred Kubbies
Journal:  Int J Oncol       Date:  2012-10-05       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.